Reckitt Benckiser Group's core brands include Lysol, Mucinex, Finish, Durex and others. - PROVIDED BY PRNEWSFOTO/LYSOL
Reckitt Benckiser Group's core brands include Lysol, Mucinex, Finish, Durex and others. - PROVIDED BY PRNEWSFOTO/LYSOL
Kimberly Redmond//April 30, 2026//
Another wave of layoffs is set to impact Reckitt Benckiser Group‘s workforce in New Jersey.
In a notice with the New Jersey Department of Labor & Workforce Development, the multinational company said it expects to let go 57 employees by March 2027.
According to Reckitt, the reductions will occur at its new headquarters at the ON3 campus in Nutley. Previously, the company’s North American base was located at Latitude in Parsippany.
A spokesperson for Reckitt did not immediately respond to a request for comment.
As part of a restructuring campaign announced in July 2024, Reckitt aims to reshape itself into a “simpler, more effective organization with fewer management layers and reduced duplication.” Reckitt has not disclosed a cumulative figure for how many layoffs have occurred globally due to the strategy. Since kicking off the restructuring, the company has issued 252 pink slips in New Jersey.
U.K.-based Reckitt employs roughly 36,000 people worldwide across its home country, the U.S., Europe and Asia.
After conducting a strategic review of its portfolio, Reckitt is moving away from its nutrition and essential home division to concentrate on core brands within the consumer health and hygiene categories.
The company recently sold a majority stake in its Essential Home business to a private equity firm in a deal worth $4.8 billion. The unit’s 75-plus brands includes Air Wick fresheners, Easy-Off oven cleaner, Calgon water softener and Resolve carpet cleaner.
According to the company, the business generated roughly $2.6 billion in net revenue and $637 million in operating profit last year — about 13% to 14% of the its total revenue.
With home care divested, Reckitt said it will prioritize the 11 remaining “powerbrands” in consumer health and hygiene, including Mucinex, Strepsils, Gaviscon, Nurofen, Lysol, Dettol, Harpic, Finish, Vanish, Durex and Veet.
According to Reckitt, the overall strategy aims to reduce annual fixed costs from the current 22% to 19% by 2027.